Mouwasat Medical Services Company acquires, manages, operates, and maintains hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia.
Mouwasat Medical Services Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||ر.س182.80|
|52 Week High||ر.س121.40|
|52 Week Low||ر.س214.60|
|1 Month Change||-7.68%|
|3 Month Change||0.99%|
|1 Year Change||48.38%|
|3 Year Change||129.07%|
|5 Year Change||217.91%|
|Change since IPO||1,171.65%|
Recent News & Updates
Mouwasat Medical Services (TADAWUL:4002) Is Achieving High Returns On Its Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
Is Mouwasat Medical Services Company (TADAWUL:4002) Expensive For A Reason? A Look At Its Intrinsic Value
Today we will run through one way of estimating the intrinsic value of Mouwasat Medical Services Company ( TADAWUL:4002...
|4002||SA Healthcare||SA Market|
Return vs Industry: 4002 underperformed the SA Healthcare industry which returned 65% over the past year.
Return vs Market: 4002 exceeded the SA Market which returned 5.2% over the past year.
Stable Share Price: 4002 is more volatile than 75% of SA stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: 4002's weekly volatility (4%) has been stable over the past year, but is still higher than 75% of SA stocks.
About the Company
|1974||n/a||Nasser Sultan Al-Subaie||https://www.mouwasat.com|
Mouwasat Medical Services Company acquires, manages, operates, and maintains hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia. It operates a network of hospitals in Dammam, Jubail, Madinah, Khobar, Qatif, and Riyadh that provides a range of medical services. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services; a fertility center; and a clinic for bariatric surgery.
Is Mouwasat Medical Services undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 4002 (SAR182.8) is trading above our estimate of fair value (SAR169.09)
Significantly Below Fair Value: 4002 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 4002 is good value based on its PE Ratio (30.8x) compared to the SA Healthcare industry average (40.9x).
PE vs Market: 4002 is good value based on its PE Ratio (30.8x) compared to the SA market (31x).
Price to Earnings Growth Ratio
PEG Ratio: 4002 is poor value based on its PEG Ratio (2.7x)
Price to Book Ratio
PB vs Industry: 4002 is overvalued based on its PB Ratio (7.9x) compared to the SA Healthcare industry average (2.8x).
How is Mouwasat Medical Services forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4002's forecast earnings growth (11.5% per year) is above the savings rate (8.8%).
Earnings vs Market: 4002's earnings (11.5% per year) are forecast to grow faster than the SA market (5.9% per year).
High Growth Earnings: 4002's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4002's revenue (11.3% per year) is forecast to grow faster than the SA market (3.1% per year).
High Growth Revenue: 4002's revenue (11.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4002's Return on Equity is forecast to be high in 3 years time (24.2%)
How has Mouwasat Medical Services performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4002 has high quality earnings.
Growing Profit Margin: 4002's current net profit margins (27.7%) are higher than last year (23.4%).
Past Earnings Growth Analysis
Earnings Trend: 4002's earnings have grown by 16.9% per year over the past 5 years.
Accelerating Growth: 4002's earnings growth over the past year (32.6%) exceeds its 5-year average (16.9% per year).
Earnings vs Industry: 4002 earnings growth over the past year (32.6%) exceeded the Healthcare industry 29.5%.
Return on Equity
High ROE: 4002's Return on Equity (25.9%) is considered high.
How is Mouwasat Medical Services's financial position?
Financial Position Analysis
Short Term Liabilities: 4002's short term assets (SAR1.2B) exceed its short term liabilities (SAR688.6M).
Long Term Liabilities: 4002's short term assets (SAR1.2B) exceed its long term liabilities (SAR708.7M).
Debt to Equity History and Analysis
Debt Level: 4002's debt to equity ratio (32.4%) is considered satisfactory.
Reducing Debt: 4002's debt to equity ratio has reduced from 39% to 32.4% over the past 5 years.
Debt Coverage: 4002's debt is well covered by operating cash flow (83.1%).
Interest Coverage: 4002's interest payments on its debt are well covered by EBIT (68x coverage).
What is Mouwasat Medical Services's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 4002's dividend (1.37%) isn’t notable compared to the bottom 25% of dividend payers in the SA market (1.49%).
High Dividend: 4002's dividend (1.37%) is low compared to the top 25% of dividend payers in the SA market (4.05%).
Stability and Growth of Payments
Stable Dividend: 4002's dividends per share have been stable in the past 10 years.
Growing Dividend: 4002's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (42.2%), 4002's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: 4002's dividends in 3 years are forecast to be covered by earnings (55.1% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Nasser Sultan Al-Subaie (66 yo)
Mr. Nasser Sultan Al-hammad Al-subaie serves as the Chief Executive Officer and Vice Chairman of Al-Mouwasat Medical Services Company. Mr. Al-subaie holds a Certificate in managing health organizations fro...
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Mouwasat Medical Services Company's employee growth, exchange listings and data sources
- Name: Mouwasat Medical Services Company
- Ticker: 4002
- Exchange: SASE
- Founded: 1974
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: ر.س18.280b
- Shares outstanding: 100.00m
- Website: https://www.mouwasat.com
- Mouwasat Medical Services Company
- Block 71 - King Fahad Road
- PO Box 282
- Saudi Arabia
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/22 15:21|
|End of Day Share Price||2021/09/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.